- Home
- OCGN vs RM Comparison
OCGN vs RM Comparison
Compare OCGN & RM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCGN
- RM
- Stock Information
- Founded
- OCGN 2013
- RM 1987
- Country
- OCGN United States
- RM United States
- Employees
- OCGN N/A
- RM N/A
- Industry
- OCGN Biotechnology: Biological Products (No Diagnostic Substances)
- RM Finance: Consumer Services
- Sector
- OCGN Health Care
- RM Finance
- Exchange
- OCGN Nasdaq
- RM Nasdaq
- Market Cap
- OCGN 278.3M
- RM 261.3M
- IPO Year
- OCGN N/A
- RM 2012
- Fundamental
- Price
- OCGN $1.03
- RM $29.45
- Analyst Decision
- OCGN Strong Buy
- RM Hold
- Analyst Count
- OCGN 3
- RM 2
- Target Price
- OCGN $6.00
- RM $30.00
- AVG Volume (30 Days)
- OCGN 8.5M
- RM 48.9K
- Earning Date
- OCGN 08-07-2025
- RM 07-30-2025
- Dividend Yield
- OCGN N/A
- RM 4.10%
- EPS Growth
- OCGN N/A
- RM 41.13
- EPS
- OCGN N/A
- RM 3.29
- Revenue
- OCGN $4,522,000.00
- RM $577,647,000.00
- Revenue This Year
- OCGN N/A
- RM $13.10
- Revenue Next Year
- OCGN N/A
- RM $9.35
- P/E Ratio
- OCGN N/A
- RM $8.89
- Revenue Growth
- OCGN N/A
- RM 6.45
- 52 Week Low
- OCGN $0.52
- RM $25.41
- 52 Week High
- OCGN $1.98
- RM $37.52
- Technical
- Relative Strength Index (RSI)
- OCGN 55.00
- RM 60.03
- Support Level
- OCGN $0.95
- RM $26.98
- Resistance Level
- OCGN $1.15
- RM $29.56
- Average True Range (ATR)
- OCGN 0.11
- RM 0.86
- MACD
- OCGN -0.02
- RM 0.26
- Stochastic Oscillator
- OCGN 22.62
- RM 98.84
About OCGN Ocugen Inc.
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").
About RM Regional Management Corp.
Regional Management Corp is a diversified consumer finance company that provides installment loan products to customers with limited access to consumer credit from banks, thrifts, credit card companies, and other lenders. It is engaged in consumer finance. The company has the core products which are small and large installment loans. The company also offers optional payment and collateral protection insurance. The company's principal source of revenue is interest and fee income on outstanding loans.